LG Chem acquires approval of the first antibody biosimilar ‘Eucept’

Published: 2018-03-20 16:29:00
Updated: 2018-03-20 16:23:35

LG Chem will aim for the Korean antibody biosimilar market.

LG Chem announced on the 16th that the company acquired approval of ‘Eucept,’ a biosimilar product referencing ‘etanercept,’ an autoimmune disease treatment, from the Ministry of Food and Drug Safety(MFDS).

Eucept, the LG Chem’s first ...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.